Citigroup’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74K | Sell |
9,010
-15,701
| -64% | -$6.52K | ﹤0.01% | 4567 |
|
|
2025
Q1 | $15.4K | Sell |
24,711
-6,725
| -21% | -$4.19K | ﹤0.01% | 4364 |
|
|
2024
Q4 | $52.5K | Buy |
31,436
+5,884
| +23% | +$9.83K | ﹤0.01% | 4226 |
|
|
2024
Q3 | $46.5K | Buy |
25,552
+17,260
| +208% | +$31.4K | ﹤0.01% | 4261 |
|
|
2024
Q2 | $50K | Sell |
8,292
-35,215
| -81% | -$212K | ﹤0.01% | 3847 |
|
|
2024
Q1 | $485K | Buy |
43,507
+38,764
| +817% | +$432K | ﹤0.01% | 2880 |
|
|
2023
Q4 | $70.6K | Buy |
4,743
+4,220
| +807% | +$62.8K | ﹤0.01% | 3613 |
|
|
2023
Q3 | $2.51K | Sell |
523
-6,616
| -93% | -$31.8K | ﹤0.01% | 4156 |
|
|
2023
Q2 | $53.6K | Buy |
7,139
+6,214
| +672% | +$46.7K | ﹤0.01% | 3932 |
|
|
2023
Q1 | $4.18K | Sell |
925
-189
| -17% | -$854 | ﹤0.01% | 4287 |
|
|
2022
Q4 | $12.6K | Sell |
1,114
-142
| -11% | -$1.6K | ﹤0.01% | 4065 |
|
|
2022
Q3 | $12K | Sell |
1,256
-1,336
| -52% | -$12.8K | ﹤0.01% | 4186 |
|
|
2022
Q2 | $21K | Sell |
2,592
-22,591
| -90% | -$183K | ﹤0.01% | 4264 |
|
|
2022
Q1 | $426K | Sell |
25,183
-61,494
| -71% | -$1.04M | ﹤0.01% | 2956 |
|
|
2021
Q4 | $1.86M | Buy |
86,677
+63,311
| +271% | +$1.36M | ﹤0.01% | 2029 |
|
|
2021
Q3 | $1.73M | Sell |
23,366
-46,103
| -66% | -$3.41M | ﹤0.01% | 2014 |
|
|
2021
Q2 | $3.8M | Buy |
69,469
+14,779
| +27% | +$808K | ﹤0.01% | 1645 |
|
|
2021
Q1 | $4.03M | Buy |
54,690
+51,499
| +1,614% | +$3.8M | ﹤0.01% | 1473 |
|
|
2020
Q4 | $275K | Sell |
3,191
-463
| -13% | -$39.9K | ﹤0.01% | 3038 |
|
|
2020
Q3 | $138K | Buy |
+3,654
| New | +$138K | ﹤0.01% | 2966 |
|